OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The next major emergent infectious disease: reflections on vaccine emergency development strategies
Yu Bai, Qian Wang, Mingchen Liu, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 471-481
Open Access | Times Cited: 18

Showing 18 citing articles:

Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8

An improved BERT method for the evolution of network public opinion of major infectious diseases: Case Study of COVID-19
Meng Su, Dongsheng Cheng, Yan Xu, et al.
Expert Systems with Applications (2023) Vol. 233, pp. 120938-120938
Closed Access | Times Cited: 11

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2

Location Decision of Emergency Medical Supply Distribution Centers Under Uncertain Environment
Liu Yong, Meiru Wang, Yong Wang
International Journal of Fuzzy Systems (2024) Vol. 26, Iss. 5, pp. 1567-1603
Closed Access | Times Cited: 1

Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats
Viktoriya Keyer, Laura Syzdykova, Gulzat Zauatbayeva, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 617-617
Open Access | Times Cited: 7

How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
Qian Wang, Xing Wu, Qunying Mao, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1119-1127
Closed Access | Times Cited: 5

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine
Dong Liu, Chaoqiang An, Yu Bai, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1854-1854
Open Access | Times Cited: 5

Development of semisynthetic saponin immunostimulants
Di Bai, Hyun Jung Kim, Pengfei Wang
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1292-1306
Open Access

Neem Seed Methanolic Extract Scavenges Free Radicals and Demonstrate Bacterial Growth Inhibition Potential
Omorefosa O. Osemwegie, Marvellous Amarachi Acho, Charles Obiora Nwonuma, et al.
(2024), pp. 1-10
Closed Access

Infectious diseases and global security: Analysis of global control and vaccination strategies
Beata Strzelecka, Ledi Neçaj, Katarzyna Wiśniewska, et al.
Salud Ciencia y Tecnología (2024) Vol. 4
Closed Access

Codon optimized influenza H1 HA sequence but not CTLA-4 targeting of HA antigen to enhance the efficacy of DNA vaccines in an animal model
Dito Anurogo, Chia‐Yuan Chen, Chu-Chi Lin, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. 1
Open Access

Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
Federico D’Alessio, Lucia Lione, Erika Salvatori, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 678-678
Open Access | Times Cited: 1

The Next Pandemic: Challenges and Hopes
Cláudia Pio Ferreira, Marie-Françoise J. Doursout, Joselito S. Balingit
Springer eBooks (2023), pp. 373-391
Closed Access

New multifunctional bromine-active polymers: synthesis, properties, and antimicrobial activity
Bohdan Murashevych, Dmitry Girenko, Mykola Toropin, et al.
Eastern-European Journal of Enterprise Technologies (2023) Vol. 2, Iss. 6 (122), pp. 32-42
Open Access

Drivers for the Emergence and re-emergence of Human Infectious Diseases, A Systematic review
Temesgen File, Bayisa Chala Chala
Research Square (Research Square) (2023)
Open Access

NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS
G.M. Zauatbayeva, L.R. Syzdykova, Viktoriya Keyer, et al.
Eurasian journal of applied biotechnology (2022), Iss. 2, pp. 44-53
Open Access

Page 1

Scroll to top